You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study
|
|---|---|
| Published in |
BMC Infectious Diseases, October 2013
|
| DOI | 10.1186/1471-2334-13-468 |
| Pubmed ID | |
| Authors |
Richa Vashishtha, Krishna Mohan, Bhagteshwar Singh, Satish K Devarapu, Vishnubhatla Sreenivas, Sanjay Ranjan, Deepak Gupta, Sanjeev Sinha, Surendra K Sharma |
| Abstract |
Despite the latest World Health Organization guidelines advocating daily therapy in HIV-TB co-infected individuals, there are few recent studies comparing outcomes of thrice-weekly anti-tuberculosis treatment in HIV-positive and HIV-negative patients with TB. The present study sets out to compare TB treatment outcomes in these two groups in the Indian national programme, which currently involves thrice-weekly therapy for all, regardless of HIV status. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | <1% |
| Unknown | 115 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 17% |
| Researcher | 16 | 14% |
| Student > Bachelor | 14 | 12% |
| Student > Ph. D. Student | 10 | 9% |
| Student > Postgraduate | 9 | 8% |
| Other | 21 | 18% |
| Unknown | 26 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 37% |
| Nursing and Health Professions | 13 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Social Sciences | 5 | 4% |
| Immunology and Microbiology | 4 | 3% |
| Other | 16 | 14% |
| Unknown | 30 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2023.
All research outputs
#7,119,049
of 24,736,359 outputs
Outputs from BMC Infectious Diseases
#2,311
of 8,300 outputs
Outputs of similar age
#60,618
of 215,384 outputs
Outputs of similar age from BMC Infectious Diseases
#36
of 140 outputs
Altmetric has tracked 24,736,359 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 8,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,384 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.